Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study tracks what pregnant women and partners really want to know

NCT ID NCT07623096

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 1,000 pregnant women and their partners from early pregnancy to about two months after birth. Participants fill out short questionnaires at key timepoints to track how their health information needs change. Some may also share data from their smartphones or wearables. The goal is to identify gaps in information and improve support for families.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help healthcare providers better understand and address the information needs of pregnant women and their partners, potentially improving support and reducing anxiety.
What could go wrong
This is an observational study with no treatment or intervention. It will not directly change medical care, and results may not apply to all populations or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants will be recruited from pregnant women aged 18 or over attending a routine first-trimester ultrasound appointment at the Harris Birthright Research Centre for Fetal Medicine, King's College Hospital, London, who are UK residents, able to give informed consent, able to read and understand English sufficiently to complete the study questionnaires, and have access to a compatible smartphone. Each pregnant participant may optionally nominate one partner - any individual identified as providing partner support, regardless of gender or relationship status - who meets the same age, residency, consent, language, and smartphone criteria. This is a demographically diverse urban NHS population.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Pregnant participants * Aged 18 years or over; * Attending a routine first-trimester ultrasound appointment at the study site; * Resident in the UK; * Able to provide informed and documented consent; * Able to read and understand English sufficiently to complete study questionnaires delivered via the study mobile application; * Have access to a compatible smartphone. Partners * Aged 18 years or over; * Nominated by a participating pregnant participant; * Resident in the UK; * Able to provide informed and documented consent; * Able to read and understand English sufficiently to complete study questionnaires delivered via the study mobile application; * Have access to a compatible smartphone. Exclusion Criteria: Pregnant participants and partners: * Under 18 years of age; * Not resident in the UK; * Unable to provide informed consent; * No access to a compatible smartphone.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pregnancy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • King's College Hospital

    London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.